Down 99%, this stock has been crushed by AI and is now a penny share!

Chegg has gone from being a fast-growth tech stock to a penny share trading for less than $1 in the space of four years. Ben McPoland explains why.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Frustrated young white male looking disconsolate while sat on his sofa holding a beer

Image source: Getty Images

The market has recently moved on from all things artificial intelligence (AI), focusing instead on global trade and tariffs. But in the background, the AI revolution continues apace and is disrupting some businesses. One is Chegg (NYSE: CHGG), which was trading for $113 in 2021 but is now priced as a penny share at $0.75.

That’s a shocking four-year decline of 99%!

An example of disruption

Chegg is an education technology company that offers services like textbook rentals, homework help, and study resources. Its customers are mainly college and high school students. 

However, as we know, generative AI bots like ChatGPT now — somewhat controversially — offer free help with homework and essays, undermining Chegg’s value proposition. Basically, students seem to be thinking: ‘why pay for Chegg when AI gives you free answers?’

In 2023, management said: “Since March we saw a significant spike in student interest in ChatGPT. We now believe it’s having an impact on our new customer growth rate.”

Chegg was right. In two years, its subscribers have gone from 5.1m to 3.2m, with revenue falling from $188m to $121m in that time. Worryingly, its cash position has fallen from $281m in Q1 2023 to just $44m at the end of March (and it’s now loss-making).

To try to improve things, the company is drastically cutting costs and exploring being acquired. Perhaps that can salvage some value (the market cap is now just $79m).

It’s also licensing its question-and-answer pairs to language model companies, though that appears to be a double-edged sword to me. Yes, it’s generating revenue by leveraging proprietary education data, but giving AI companies its content could cannibalise the core subscription business.

Today (12 May), Chegg’s management wrote: “We believe the trends impacting our business will worsen before they get better.”

Those “trends” are, of course, mainly declining subscribers due to competition from generative AI.

AI is not a single event

Many people have likened AI to the internet, but it does appear different to me.

While revolutionary, the internet was a one-time platform shift. But AI is not a single watershed moment. Rather, it’s a self-improving force, constantly learning and evolving, perhaps exponentially. 

Consequently, I expect a lot more disruption — and potential opportunities — in the years ahead.

This stock looks in no danger from AI

Of course, there will be some businesses that AI won’t hurt. It should even make them more efficient and profitable. Many of these can be found in the FTSE 100, including miners, global banks, and oil giants.

One UK stock that might be worth considering is AstraZeneca. It’s down 16% since March as investors worry about the Trump administration’s drive to lower drug prices in the US. This is a risk worth mentioning, as the US is AstraZeneca’s largest market.

However, in terms of AI, the technology could actually turbocharge the company’s drug discovery process. Not only that, but AstraZeneca has the wherewithal to really invest in its AI capabilities, unlike most smaller upstarts.

To me, the firm looks more likely to benefit from AI than be threatened by it. With the stock trading at a reasonable 15 times forward earnings, I think it’s worth a look.

Ben McPoland has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Workers at Whiting refinery, US
Investing Articles

Why is everyone selling BP shares?

BP shares have been some of the most sold in the last week. What's going on here? And could this…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Is this market correction a once-in-a-decade chance to buy ultra-high-yield income stocks?

As share prices fall, dividend yields rise. The FTSE 100 is full of top income stocks and Harvey Jones says…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Down 25% in a month! Are these the 3 best stocks to buy in today’s correction… or the worst?

Harvey Jones examines whether the best stocks to buy today can all be found in the FTSE 100 sector that…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

This FTSE small-cap stock can surge 105%, says one broker

Ben McPoland highlights a FTSE small-cap share that's trading cheaply and offering a dividend for the first time since 2019.

Read more »

A mature adult sitting by a fireplace in a living room at home. She is wearing a yellow cardigan and spectacles.
Investing Articles

£10,000 invested in ultra-high yield Legal & General shares on 5 April last year is now worth…

Investors typically buy Legal & General shares for the dividend income, as they now yield more than 8.5%. But will…

Read more »

Modern apartments on both side of river Irwell passing through Manchester city centre, UK.
Investing Articles

With an empty ISA today, how long would it take to aim for a million?

Is it realistic to aim for a million with an empty ISA? Our writer turns from fantasy to facts to…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

What on earth’s going on with the Helium One share price?

The Helium One share price rally has stalled. Our writer reflects on the reasons and asks whether now could be…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Getting started with investing? Here are 3 UK stocks to take a look at

The next time the stock market opens, it will be the new financial year. And Stephen Wright has three UK…

Read more »